MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
Funding: U.S. Federal
*Funding: HHS
*HHS: Contracts, Contractors & Awards
*BARDA: Contracts (IDIQ, GWACS, Etc.), Contractors & Awardees
*Contractors & Awardees: BARDA
Cerus Corporation (NASDAQ:CERS)*
Organization & Developments: Cerus
Parents
Cerus Corporation (NASDAQ:CERS)*
Children
*Blood Safety and Decontamination
*Cancer vaccine development
*Immunomodulation
*Improved Vaccine Production
*INTERCEPT BLOOD SYSTEM FOR PLASMA
*INTERCEPT Platelets, Plasma, Red Cells
*Listeria vaccine platform
*The company's INTERCEPT system is one of the world's leading blood safety devices and has already proven its efficacy against other coronaviruses
2019: Finding Steady Growth In Cerus Corporation For 2019_seekingalpha.com
2020: Cerus Corporation Announces Five-Year FDA Contract for the Development of Next Generation Pathogen Reduction Technology to Treat Whole Blood_Cerus
2020: Cerus: Surging During The COVID-19 Pandemic
2021: Cerus Corp.: Remaining Bullish Despite Delayed Compliance Date
2022: Cerus: Technical Support Fades, Investment Case Weakens (Technical Analysis)_ seekingalpha.com
2023: Cerus Corporation: Cash Burn Remains Concerning
Jumps
*Key People: Cerus
Finance & Acquisitions: Cerus